BioVie completes treatment visits in a phase 2 long COVID trial of bezisterim targeting brain fog and fatigue, with topline results expected September 2026.
|Slideshows|November 23, 2020
Top 10 Reasons to be Grateful During the COVID-19 Pandemic
Author(s)Peter F. Buckley, MD
As the countdown to the new year slowly dwindles down, remember the things you can be thankful for in 2020, as hard as it may have been.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval
2
Vol 43, Issue 9 - Interactive
3
Debunking the Top 10 Misleading Claims About Antidepressants
4
What Low Doses of VRAYLAR® (Cariprazine) May Mean for Clinical Practice
5